Form 4 holding
10%+ Owner
Homology Medicines, Inc.
- Security class
- Common Stock
- Shares / value
- 864,261
- Estimated value
- $493,579
- Report date
- 25 Mar 2024
- Price
- $0.5711
- Ownership
- Direct
Atlas Venture Fund X, L.P. - 10%+ Owner at Q32 Bio Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- QTTB on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Atlas Venture Fund X, L.P. since 21 Aug 2025
Reported holdings for Atlas Venture Fund X, L.P. in Q32 Bio Inc.
Form 4 holding
10%+ Owner
Homology Medicines, Inc.
- Security class
- Common Stock
- Shares / value
- 724,549
- Estimated value
- $413,790
- Report date
- 25 Mar 2024
- Price
- $0.5711
- Ownership
- By Atlas Venture Opportunity Fund II, L.P.
Form 4 holding
10%+ Owner
Homology Medicines, Inc.
- Security class
- Common Stock
- Shares / value
- 503,296
- Estimated value
- $287,432
- Report date
- 25 Mar 2024
- Price
- $0.5711
- Ownership
- By Atlas Venture Opportunity Fund I, L.P.
Transaction history for Atlas Venture Fund X, L.P. in Q32 Bio Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.